Chemicals · Founded 1970 · www.srf.com · BSE 503806 · NSE SRF LIMITED · ISIN INE647A01010
No Notes Added Yet
Business
SRF Ltd. is a diversified chemical conglomerate primarily engaged in the manufacturing of industrial intermediates. Its core business revolves around producing a wide range of specialized chemicals, technical textiles, and packaging films. The company makes money by developing, manufacturing, and selling these products to various B2B customers globally, including those in the automotive, pharmaceutical, agrochemical, food packaging, and consumer durable industries. SRF focuses on value-added and niche products, often through backward integration and strong R&D capabilities.
Revenue Mix
SRF operates through three primary business segments:
Chemicals Business: This is the largest and most significant segment, encompassing Fluorochemicals (refrigerants, pharmaceutical intermediates, agrochemical intermediates) and Specialty Chemicals (agrochemical and pharmaceutical intermediates, custom synthesis manufacturing). This segment typically contributes over 50% of the company's revenue and a higher proportion of its profitability, and has been the primary growth driver.
Packaging Films Business: Manufactures a range of BOPET (Biaxially-Oriented Polyethylene Terephthalate) and BOPP (Biaxially-Oriented Polypropylene) films used for packaging, labeling, and industrial applications.
Technical Textiles Business: Produces Tyre Cord Fabrics, Belting Fabrics, Industrial Yarns, and Coated Fabrics, serving automotive, industrial, and infrastructure sectors.
Industry
SRF operates in the highly competitive and capital-intensive chemical industry.
Chemicals: SRF is a leading player in India for several fluorochemicals and has established itself as a preferred partner for custom synthesis manufacturing (CSM) for global agrochemical and pharmaceutical majors. It leverages strong R&D and process capabilities to develop complex molecules.
Technical Textiles: Holds a dominant position in India for Nylon Tyre Cord Fabrics, supplying to major tire manufacturers.
Packaging Films: A significant player in the global BOPET and BOPP film markets, competing with large domestic and international producers. The industry can be cyclical and prone to capacity additions.
SRF's diversified portfolio and focus on specialized products allow it to maintain strong positioning across its chosen niches.
MOAT
Technology & R&D: SRF's strong focus on research and development, particularly in fluorochemistry and specialty chemicals, enables it to develop proprietary processes and complex molecules, creating higher barriers to entry for competitors.
Backward Integration: Significant backward integration in its chemicals business (e.g., manufacturing key raw materials like anhydrous hydrofluoric acid) provides cost advantages and supply security.
Diversified Product Portfolio: The presence across three distinct business segments provides resilience against downturns in any single industry and offers a broader revenue base.
Customer Stickiness (Specialty Chemicals): Long-term engagements, complex product development cycles, and stringent quality requirements in specialty chemicals often lead to high switching costs for clients.
Global Scale and Presence: Manufacturing facilities and sales networks across multiple geographies enhance its reach and derisk its operations.
Growth Drivers
Specialty Chemicals and CSM: Continued outsourcing trends by global agrochemical and pharmaceutical companies (China+1 strategy) driving demand for custom synthesis and contract manufacturing services in India.
Fluorochemicals: Growing demand for new-generation refrigerants (HFOs), increased application in electric vehicle batteries, and intermediates for pharma/agro industries.
Capacity Expansions: Ongoing significant capital expenditure across all segments, particularly chemicals, to cater to anticipated demand growth.
R&D and New Product Development: Focus on expanding its product basket and developing value-added solutions, moving up the value chain.
Export Opportunities: Leveraging its global certifications and cost competitiveness to increase exports, especially in chemicals and films.
Risks
Raw Material Price Volatility: Fluctuations in prices of key inputs such as crude oil derivatives (for films), fluorospar, and other chemical intermediates can impact margins.
Environmental Regulations: The chemical industry is subject to stringent and evolving environmental, health, and safety regulations, which can lead to higher compliance costs or operational restrictions.
Cyclicality and Competition: The packaging films business is highly competitive, cyclical, and susceptible to overcapacity, leading to pricing pressure. Some textile segments are also exposed to economic cycles.
Currency Fluctuations: As a significant exporter and importer, SRF is exposed to foreign exchange rate volatility.
Capital Intensity: The business requires substantial capital expenditure for expansion and modernization, which can impact cash flows and leverage.
Geopolitical Risks: Global trade tensions and supply chain disruptions could impact operations and profitability.
Management & Ownership
SRF Ltd. is a promoter-led company with the Arun Bharat Ram family holding a significant stake. The promoter group, comprising the Bharat Ram family, has a long history and deep understanding of the business, guiding its strategic direction. The company is professionally managed with a focus on R&D, operational efficiency, and sustainable growth. The ownership structure includes a substantial stake by the promoter group (around 50%), with the remaining held by institutional investors (FIIs, DIIs) and the public, indicating broad institutional confidence.
Outlook
SRF is well-positioned to benefit from long-term growth trends in specialty chemicals and fluorochemicals, driven by global outsourcing and increasing demand for advanced materials. Its diversified business model provides some resilience, and its focus on R&D and backward integration offers a competitive edge. However, the company faces inherent challenges from raw material price volatility, intense competition in its more commoditized segments like packaging films, and the need for continuous, significant capital expenditure. The ability to successfully execute its ongoing capacity expansions and navigate regulatory complexities will be key to its future performance.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 3053 | 3570 | 3464 | 3424 | 3491 | 4313 | 3819 | 3640 | 3713 | 4615 |
| Other Income | 19 | 23 | 25 | 33 | 40 | 34 | 38 | 26 | 27 | 25 |
| Total Income | 3072 | 3593 | 3489 | 3458 | 3531 | 4348 | 3856 | 3666 | 3740 | 4640 |
| Total Expenditure | 2487 | 2874 | 2861 | 2886 | 2872 | 3356 | 2997 | 2866 | 2933 | 3589 |
| Operating Profit | 585 | 719 | 629 | 571 | 659 | 992 | 859 | 800 | 807 | 1051 |
| Interest | 67 | 90 | 97 | 94 | 96 | 89 | 80 | 71 | 66 | 62 |
| Depreciation | 169 | 186 | 188 | 194 | 194 | 195 | 203 | 212 | 217 | 220 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -73 | -12 |
| Profit Before Tax | 348 | 443 | 344 | 284 | 369 | 707 | 576 | 517 | 452 | 757 |
| Provision for Tax | 95 | 21 | 92 | 82 | 98 | 181 | 144 | 129 | 19 | 175 |
| Profit After Tax | 253 | 422 | 252 | 201 | 271 | 526 | 432 | 388 | 433 | 582 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 253 | 422 | 252 | 201 | 271 | 526 | 432 | 388 | 433 | 582 |
| Adjusted Earnings Per Share | 8.5 | 14.2 | 8.5 | 6.8 | 9.1 | 17.7 | 14.6 | 13.1 | 14.6 | 19.6 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 4540 | 4593 | 4822 | 5589 | 7100 | 7209 | 8400 | 12434 | 14870 | 13139 | 14693 | 15787 |
| Other Income | 65 | 28 | 73 | 115 | 28 | 49 | 66 | 116 | 75 | 83 | 133 | 116 |
| Total Income | 4604 | 4621 | 4895 | 5704 | 7128 | 7258 | 8466 | 12549 | 14945 | 13222 | 14826 | 15902 |
| Total Expenditure | 3822 | 3630 | 3853 | 4683 | 5803 | 5754 | 6267 | 9330 | 11341 | 10554 | 11975 | 12385 |
| Operating Profit | 782 | 990 | 1042 | 1021 | 1325 | 1504 | 2200 | 3219 | 3604 | 2667 | 2851 | 3517 |
| Interest | 138 | 130 | 102 | 124 | 198 | 201 | 134 | 116 | 205 | 302 | 376 | 279 |
| Depreciation | 245 | 275 | 283 | 316 | 358 | 389 | 453 | 517 | 575 | 673 | 772 | 852 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -85 |
| Profit Before Tax | 399 | 585 | 657 | 582 | 768 | 915 | 1613 | 2586 | 2824 | 1692 | 1704 | 2302 |
| Provision for Tax | 97 | 155 | 142 | 120 | 177 | -1 | 414 | 697 | 662 | 357 | 453 | 467 |
| Profit After Tax | 303 | 430 | 515 | 462 | 592 | 916 | 1198 | 1889 | 2162 | 1336 | 1251 | 1835 |
| Adjustments | 0 | 0 | 0 | 0 | 50 | 103 | -0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 303 | 430 | 515 | 462 | 642 | 1019 | 1198 | 1889 | 2162 | 1336 | 1251 | 1835 |
| Adjusted Earnings Per Share | 10.5 | 15 | 17.9 | 16.1 | 22.3 | 35.5 | 40.4 | 63.7 | 72.9 | 45.1 | 42.2 | 61.9 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 12% | 6% | 15% | 12% |
| Operating Profit CAGR | 7% | -4% | 14% | 14% |
| PAT CAGR | -6% | -13% | 6% | 15% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -5% | 3% | 16% | 27% |
| ROE Average | 10% | 15% | 18% | 17% |
| ROCE Average | 12% | 16% | 18% | 15% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 2296 | 2763 | 3183 | 3565 | 4129 | 4933 | 6856 | 8565 | 10327 | 11479 | 12626 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 1788 | 1940 | 1432 | 1907 | 2161 | 2312 | 1965 | 1753 | 2312 | 2251 | 1981 |
| Other Non-Current Liabilities | 405 | 299 | 344 | 359 | 399 | 310 | 519 | 1006 | 1181 | 1243 | 1484 |
| Total Current Liabilities | 1393 | 1421 | 2010 | 2532 | 3199 | 3308 | 3571 | 4440 | 4917 | 5481 | 5430 |
| Total Liabilities | 5883 | 6424 | 6968 | 8363 | 9888 | 10863 | 12911 | 15765 | 18736 | 20454 | 21521 |
| Fixed Assets | 3922 | 4113 | 4405 | 5122 | 5609 | 6368 | 7827 | 8425 | 10050 | 13242 | 13720 |
| Other Non-Current Assets | 244 | 328 | 484 | 816 | 1106 | 1589 | 1145 | 2085 | 2911 | 1563 | 1672 |
| Total Current Assets | 1716 | 1984 | 2079 | 2426 | 3172 | 2894 | 3939 | 5251 | 5775 | 5649 | 6130 |
| Total Assets | 5883 | 6424 | 6968 | 8363 | 9888 | 10863 | 12911 | 15765 | 18736 | 20454 | 21521 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 75 | 99 | 340 | 88 | 87 | 190 | 116 | 138 | 450 | 608 | 399 |
| Cash Flow from Operating Activities | 542 | 1090 | 645 | 678 | 896 | 1304 | 1772 | 2106 | 2902 | 2094 | 2487 |
| Cash Flow from Investing Activities | -500 | -667 | -613 | -1195 | -1014 | -1180 | -1500 | -1588 | -2961 | -2227 | -1484 |
| Cash Flow from Financing Activities | -18 | -182 | -284 | 495 | 246 | -199 | -251 | -207 | 220 | -72 | -1071 |
| Net Cash Inflow / Outflow | 24 | 241 | -252 | -22 | 127 | -75 | 21 | 311 | 160 | -205 | -67 |
| Closing Cash & Cash Equivalent | 99 | 340 | 88 | 87 | 190 | 116 | 138 | 450 | 608 | 399 | 334 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 10.55 | 14.97 | 17.94 | 16.08 | 22.33 | 35.46 | 40.44 | 63.72 | 72.95 | 45.06 | 42.2 |
| CEPS(Rs) | 19.08 | 24.55 | 27.81 | 27.08 | 33.05 | 45.39 | 55.75 | 81.17 | 92.36 | 67.75 | 68.22 |
| DPS(Rs) | 10 | 10 | 12 | 12 | 12 | 14 | 24 | 16.75 | 7.2 | 7.2 | 7.2 |
| Book NAV/Share(Rs) | 78.93 | 96.2 | 110.82 | 124.12 | 143.62 | 171.56 | 231.36 | 288.82 | 347.97 | 386.54 | 424.97 |
| Core EBITDA Margin(%) | 14.74 | 19.65 | 18.86 | 15.65 | 18.61 | 19.9 | 24.97 | 24.74 | 23.41 | 19.24 | 18.21 |
| EBIT Margin(%) | 11.03 | 14.61 | 14.78 | 12.18 | 13.87 | 15.26 | 20.44 | 21.54 | 20.09 | 14.85 | 13.93 |
| Pre Tax Margin(%) | 8.21 | 11.94 | 12.79 | 10.04 | 11.03 | 12.51 | 18.88 | 20.62 | 18.74 | 12.6 | 11.41 |
| PAT Margin (%) | 6.22 | 8.78 | 10.03 | 7.97 | 8.49 | 12.53 | 14.03 | 15.06 | 14.35 | 9.94 | 8.38 |
| Cash Profit Margin (%) | 11.26 | 14.39 | 15.54 | 13.43 | 13.63 | 17.85 | 19.33 | 19.18 | 18.16 | 14.95 | 13.54 |
| ROA(%) | 5.33 | 6.99 | 7.69 | 6.02 | 6.48 | 8.83 | 10.08 | 13.17 | 12.54 | 6.82 | 5.96 |
| ROE(%) | 14.08 | 17.1 | 17.33 | 13.69 | 15.38 | 20.22 | 20.34 | 24.51 | 22.91 | 12.27 | 10.4 |
| ROCE(%) | 12.05 | 14.34 | 13.98 | 11.49 | 13.27 | 13.25 | 18.17 | 24.17 | 22.62 | 12.83 | 12.35 |
| Receivable days | 48.83 | 41.92 | 41.62 | 42.15 | 44.76 | 47.93 | 46.26 | 44.63 | 43.32 | 50.66 | 50.26 |
| Inventory Days | 56.62 | 53.45 | 53.62 | 56.61 | 57.16 | 60.57 | 56.97 | 52.45 | 53.43 | 62.51 | 57.14 |
| Payable days | 43.97 | 54.89 | 92.15 | 111.54 | 105.17 | 111.92 | 111.9 | 94.08 | 80.31 | 86.44 | 76.8 |
| PER(x) | 18.77 | 17.44 | 18.13 | 24.35 | 21.54 | 15.68 | 26.74 | 42.03 | 32.98 | 56.76 | 69.66 |
| Price/Book(x) | 2.51 | 2.71 | 2.93 | 3.15 | 3.35 | 3.24 | 4.67 | 9.27 | 6.92 | 6.62 | 6.92 |
| Dividend Yield(%) | 1.01 | 0.77 | 0.74 | 0.61 | 0.5 | 0.5 | 0.44 | 0.63 | 0.3 | 0.28 | 0.25 |
| EV/Net Sales(x) | 1.76 | 2.1 | 2.41 | 2.56 | 2.44 | 2.76 | 4.18 | 6.63 | 5.05 | 6.11 | 6.22 |
| EV/Core EBITDA(x) | 10.25 | 9.72 | 11.16 | 13.99 | 13.09 | 13.23 | 15.97 | 25.62 | 20.83 | 30.12 | 32.06 |
| Net Sales Growth(%) | 12.99 | 1.16 | 4.99 | 15.91 | 27.03 | 1.55 | 16.51 | 48.02 | 19.6 | -11.65 | 11.83 |
| EBIT Growth(%) | 76.6 | 33.22 | 6.09 | -7.04 | 37.03 | 15.37 | 56.59 | 54.67 | 12.12 | -34.15 | 4.27 |
| PAT Growth(%) | 86.39 | 41.97 | 19.8 | -10.35 | 28.13 | 54.82 | 30.83 | 57.64 | 14.47 | -38.23 | -6.36 |
| EPS Growth(%) | 86.39 | 41.97 | 19.8 | -10.35 | 38.82 | 58.83 | 14.06 | 57.56 | 14.48 | -38.23 | -6.36 |
| Debt/Equity(x) | 1.07 | 0.91 | 0.75 | 0.88 | 0.9 | 0.82 | 0.49 | 0.41 | 0.42 | 0.43 | 0.37 |
| Current Ratio(x) | 1.23 | 1.4 | 1.03 | 0.96 | 0.99 | 0.87 | 1.1 | 1.18 | 1.17 | 1.03 | 1.13 |
| Quick Ratio(x) | 0.68 | 0.92 | 0.62 | 0.58 | 0.61 | 0.51 | 0.69 | 0.7 | 0.71 | 0.61 | 0.7 |
| Interest Cover(x) | 3.9 | 5.48 | 7.46 | 5.7 | 4.87 | 5.56 | 13.04 | 23.3 | 14.79 | 6.6 | 5.53 |
| Total Debt/Mcap(x) | 0.43 | 0.34 | 0.26 | 0.28 | 0.27 | 0.25 | 0.11 | 0.04 | 0.06 | 0.06 | 0.05 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 50.53 | 50.3 | 50.26 | 50.26 | 50.26 | 50.26 | 50.26 | 50.26 | 50.26 | 50.26 |
| FII | 19.57 | 19.06 | 18.73 | 18.26 | 18.34 | 18.25 | 18.23 | 17.98 | 17.48 | 16.66 |
| DII | 14.54 | 15.99 | 16.58 | 17.82 | 17.83 | 18.48 | 18.88 | 19.56 | 20.21 | 21.2 |
| Public | 15.36 | 14.65 | 14.43 | 13.66 | 13.57 | 13.01 | 12.62 | 12.2 | 12.05 | 11.88 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 14.98 | 14.91 | 14.9 | 14.9 | 14.9 | 14.9 | 14.9 | 14.9 | 14.9 | 14.9 |
| FII | 5.8 | 5.65 | 5.55 | 5.41 | 5.44 | 5.41 | 5.4 | 5.33 | 5.18 | 4.94 |
| DII | 4.31 | 4.74 | 4.91 | 5.28 | 5.28 | 5.48 | 5.6 | 5.8 | 5.99 | 6.28 |
| Public | 4.55 | 4.34 | 4.28 | 4.05 | 4.02 | 3.86 | 3.74 | 3.62 | 3.57 | 3.52 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 29.64 | 29.64 | 29.64 | 29.64 | 29.64 | 29.64 | 29.64 | 29.64 | 29.64 | 29.64 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +12% | +6% | +15% | +12% |
| Operating Profit CAGR | +7% | -4% | +14% | +14% |
| PAT CAGR | -6% | -13% | +6% | +15% |
| Share Price CAGR | -5% | +3% | +16% | +27% |
| ROE Average | +10% | +15% | +18% | +17% |
| ROCE Average | +12% | +16% | +18% | +15% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 50.53 | 50.3 | 50.26 | 50.26 | 50.26 | 50.26 | 50.26 | 50.26 | 50.26 | 50.26 |
| FII | 19.57 | 19.06 | 18.73 | 18.26 | 18.34 | 18.25 | 18.23 | 17.98 | 17.48 | 16.66 |
| DII | 14.54 | 15.99 | 16.58 | 17.82 | 17.83 | 18.48 | 18.88 | 19.56 | 20.21 | 21.2 |
| Public | 49.47 | 49.7 | 49.74 | 49.74 | 49.74 | 49.74 | 49.74 | 49.74 | 49.74 | 49.74 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 14.98 | 14.91 | 14.9 | 14.9 | 14.9 | 14.9 | 14.9 | 14.9 | 14.9 | 14.9 |
| FII | 5.8 | 5.65 | 5.55 | 5.41 | 5.44 | 5.41 | 5.4 | 5.33 | 5.18 | 4.94 |
| DII | 4.31 | 4.74 | 4.91 | 5.28 | 5.28 | 5.48 | 5.6 | 5.8 | 5.99 | 6.28 |
| Public | 14.66 | 14.73 | 14.74 | 14.74 | 14.74 | 14.74 | 14.74 | 14.74 | 14.74 | 14.74 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 29.64 | 29.64 | 29.64 | 29.64 | 29.64 | 29.64 | 29.64 | 29.64 | 29.64 | 29.64 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.